The Supreme Court unanimously rejected a challenge on June 13 to restrict access to mifepristone, part of a two-drug regimen used to induce medical abortions. The high court concluded a group of anti-abortion doctors that brought the case forward lacked standing to challenge the Food and Drug Administration’s prior regulatory approval of the pill. NY...
